Emerging Health Technologies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials on Care Robots
-
By
-
Gaeun Kim
-
Jinmi Jeon
-
June 30, 2026
By
Gaeun Kim
Jinmi Jeon
June 30, 2026
by Gaeun Kim, Jinmi Jeon
June 30, 2026
The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.
This American Epilepsy Society (AES) practice guideline provides updated, evidence-based recommendations for the management of epilepsy in infants and children aged 1 month to <36 months.
Survey results reveal the long-term socio-economic and psychological impacts of single ventricle congenital heart disease (SVHD) on families. See how cardiologists Deepti Bhat, MD, and Naim Duran, MD, contributors to this research, are using findings to transform Fontan Clinic care at Phoenix Children’s.